NCT06474338 AI Detection of Bladder Tumors Under Endoscopy
| NCT ID | NCT06474338 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Peking Union Medical College Hospital |
| Condition | Bladder Tumor |
| Study Type | OBSERVATIONAL |
| Enrollment | 1,000 participants |
| Start Date | 2024-01-01 |
| Primary Completion | 2033-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 1,000 participants in total. It began in 2024-01-01 with a primary completion date of 2033-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this clinical trial is to learn if the AI algorithm can detect bladder tumors better than urologists under cystoscopy. It will also train the AI algorithm for bladder tumor detection. The main question it aims to answer is: Can AI algorithm achieve IOU value, precision, recall, false negative rate of bladder tumor detection similar to that of urologists? The cystoscopy video will be annotated by AI and urologists. Researchers will compare AI algorithm to urologists to see if Al algorithm has a similar capability as urologists do.
Eligibility Criteria
Inclusion Criteria: The patient who receives cystoscopy and the cystoscopy video is available, and one or multiple bladder lesions can be observed in the cystoscopy. Exclusion Criteria: The patient whose cystoscopy is not clear enough to analyze.
Contact & Investigator
Zixing Ye
PRINCIPAL INVESTIGATOR
Peking Union Medical College Hospital
Frequently Asked Questions
Who can join the NCT06474338 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 100 Years, studying Bladder Tumor. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06474338 currently recruiting?
Yes, NCT06474338 is actively recruiting participants. Contact the research team at yezixing@pumch.cn for enrollment information.
Where is the NCT06474338 trial being conducted?
This trial is being conducted at Beijing, China.
Who is sponsoring the NCT06474338 clinical trial?
NCT06474338 is sponsored by Peking Union Medical College Hospital. The principal investigator is Zixing Ye at Peking Union Medical College Hospital. The trial plans to enroll 1,000 participants.